Table 4.
[11C]NNC112 BPND by Diagnostic Group for PFCa and Striatal ROIs
ROI | Controls (n=21) | SPD (n=18) | pb |
---|---|---|---|
PFC: | |||
DLPFC | 1.35 ± 0.22 | 1.28 ± 0.27 | 0.369 |
MPFC | 1.40 ± 0.24 | 1.28 ± 0.25c | 0.172 |
OFC | 1.40 ± 0.34 | 1.39 ± 0.30 | 0.960 |
| |||
Striatal: | |||
VST | 2.50 ± 0.49 | 2.78 ± 0.44 | 0.064 |
preDCA | 2.90 ± 0.59 | 2.94 ± 0.45 | 0.792 |
preDPU | 3.08 ± 0.65 | 3.14 ± 0.53 | 0.772 |
postCA | 2.19 ± 0.41 | 2.20 ± 0.48 | 0.969 |
postPU | 2.96 ± 0.60 | 2.98 ± 0.50 | 0.885 |
whole STR | 2.86 ± 0.54 | 2.94 ± 0.46 | 0.618 |
Note. Mean ± Standard Deviation (observed).
STR=striatum; see Table 2 for other abbreviations.
BPND values for all PFC (but not striatal) ROIs were adjusted to correct for partial volume effects (PVE); see text.
Group comparisons of the estimated marginal means derived from linear mixed modeling (see text) with the exception of the composite whole STR; for this region, an independent-samples t-test was used.
n=17: One SPD participant’s values were excluded due to excessive noise in the VT measurement.